Your browser doesn't support javascript.
loading
The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019.
Ascierto, Paolo A; Bifulco, Carlo; Galon, Jerome; Garbe, Claus; Khleif, Samir N; McQuade, Jennifer; Odunsi, Kunle; Okada, Hideho; Paulos, Chrystal M; Quezada, Sergio A; Tawbi, Hussein A; Timmerman, John; Trinchieri, Giorgio; Butterfield, Lisa H; Puzanov, Igor.
Afiliação
  • Ascierto PA; Cancer Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy paolo.ascierto@gmail.com.
  • Bifulco C; Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon, USA.
  • Galon J; Laboratory of Integrative Cancer Immunology, Equipe Labellisée Ligue Contre le Cancer, Centre de Recherche des Cordeliers, INSERM, Paris, Île-de-France, France.
  • Garbe C; Center for Dermatooncology, Department of Dermatology, Eberhard Karls University Tübingen, Tubingen, Baden-Württemberg, Germany.
  • Khleif SN; The Loop Immuno-Oncology Research Laboratory, Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, USA.
  • McQuade J; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Odunsi K; Center for Immunotherapy and Department of Gynaecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Okada H; Department of Neurological Surgery, Parker Institute for Cancer Immunotherapy, UCSF, San Francisco, California, USA.
  • Paulos CM; Department of Microbiology and Immunology Hollings Cancer Center, MUSC, Charleston, South Carolina, USA.
  • Quezada SA; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
  • Tawbi HA; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Timmerman J; Santa Monica UCLA Medical Center, University of California Los Angeles, Los Angeles, California, USA.
  • Trinchieri G; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Butterfield LH; PICI Research and Development, Parker Institute for Cancer Immunotherapy, UCSF, San Francisco, California, USA.
  • Puzanov I; Early Phase Clinical Trials Program, Developmental Therapeutics Program, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
J Immunother Cancer ; 8(2)2020 08.
Article em En | MEDLINE | ID: mdl-32843491
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido